| __timestamp | AstraZeneca PLC | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 13673000 |
| Thursday, January 1, 2015 | 5997000000 | 14358000 |
| Friday, January 1, 2016 | 5890000000 | 12203000 |
| Sunday, January 1, 2017 | 5757000000 | 18125000 |
| Monday, January 1, 2018 | 5932000000 | 17071000 |
| Tuesday, January 1, 2019 | 5958000000 | 20018000 |
| Wednesday, January 1, 2020 | 5991000000 | 32788000 |
| Friday, January 1, 2021 | 9736000000 | 44966000 |
| Saturday, January 1, 2022 | 9762000000 | 311681000 |
| Sunday, January 1, 2023 | 10935000000 | 77707000 |
| Monday, January 1, 2024 | 13583000000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. AstraZeneca PLC and Lantheus Holdings, Inc. provide a fascinating contrast in their R&D investments over the past decade. From 2014 to 2023, AstraZeneca's R&D expenses have surged by nearly 96%, peaking at over $10 billion in 2023. This reflects their aggressive pursuit of new therapies and treatments. In contrast, Lantheus Holdings, Inc. has shown a more modest increase, with R&D spending growing by approximately 470% over the same period, reaching around $78 million in 2023. While AstraZeneca's absolute spending dwarfs that of Lantheus, the latter's significant percentage increase highlights its growing focus on innovation. This comparison underscores the diverse strategies companies employ to stay competitive in the pharmaceutical industry.
Eli Lilly and Company vs Lantheus Holdings, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Sanofi and Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Blueprint Medicines Corporation or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Research and Development Investment: Lantheus Holdings, Inc. vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Lantheus Holdings, Inc. vs Alkermes plc
R&D Insights: How Lantheus Holdings, Inc. and Perrigo Company plc Allocate Funds